The Roles of Neuropeptide Y in Respiratory Disease Pathogenesis via the Airway Immune Response.

IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
Junko Itano, Katsuyuki Kiura, Yoshinobu Maeda, Nobuaki Miyahara
{"title":"The Roles of Neuropeptide Y in Respiratory Disease Pathogenesis via the Airway Immune Response.","authors":"Junko Itano, Katsuyuki Kiura, Yoshinobu Maeda, Nobuaki Miyahara","doi":"10.18926/AMO/66912","DOIUrl":null,"url":null,"abstract":"<p><p>The lungs are very complex organs, and the respiratory system performs the dual roles of repairing tissue while protecting against infection from various environmental stimuli. Persistent external irritation disrupts the immune responses of tissues and cells in the respiratory system, ultimately leading to respiratory disease. Neuropeptide Y (NPY) is a 36-amino-acid polypeptide and a neurotransmitter that regulates homeostasis. The NPY receptor is a seven-transmembrane-domain G-protein-coupled receptor with six subtypes (Y1, Y2, Y3, Y4, Y5, and Y6). Of these receptors, Y1, Y2, Y4, and Y5 are functional in humans, and Y1 plays important roles in the immune responses of many organs, including the respiratory system. NPY and the Y1 receptor have critical roles in the pathogenesis of asthma, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The effects of NPY on the airway immune response and pathogenesis differ among respiratory diseases. This review focuses on the involvement of NPY in the airway immune response and pathogenesis of various respiratory diseases.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"78 2","pages":"95-106"},"PeriodicalIF":0.6000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta medica Okayama","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18926/AMO/66912","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

The lungs are very complex organs, and the respiratory system performs the dual roles of repairing tissue while protecting against infection from various environmental stimuli. Persistent external irritation disrupts the immune responses of tissues and cells in the respiratory system, ultimately leading to respiratory disease. Neuropeptide Y (NPY) is a 36-amino-acid polypeptide and a neurotransmitter that regulates homeostasis. The NPY receptor is a seven-transmembrane-domain G-protein-coupled receptor with six subtypes (Y1, Y2, Y3, Y4, Y5, and Y6). Of these receptors, Y1, Y2, Y4, and Y5 are functional in humans, and Y1 plays important roles in the immune responses of many organs, including the respiratory system. NPY and the Y1 receptor have critical roles in the pathogenesis of asthma, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The effects of NPY on the airway immune response and pathogenesis differ among respiratory diseases. This review focuses on the involvement of NPY in the airway immune response and pathogenesis of various respiratory diseases.

神经肽 Y 通过气道免疫反应在呼吸道疾病发病机制中的作用
肺是非常复杂的器官,呼吸系统具有双重作用,既要修复组织,又要抵御各种环境刺激带来的感染。持续的外界刺激会破坏呼吸系统组织和细胞的免疫反应,最终导致呼吸系统疾病。神经肽 Y(NPY)是一种含有 36 个氨基酸的多肽,也是一种调节体内平衡的神经递质。NPY 受体是一种七跨膜域 G 蛋白偶联受体,有六个亚型(Y1、Y2、Y3、Y4、Y5 和 Y6)。在这些受体中,Y1、Y2、Y4 和 Y5 在人体中具有功能,Y1 在包括呼吸系统在内的许多器官的免疫反应中发挥着重要作用。NPY 和 Y1 受体在哮喘、慢性阻塞性肺病和特发性肺纤维化的发病机制中起着关键作用。NPY 对气道免疫反应和发病机制的影响因呼吸系统疾病而异。本综述重点探讨 NPY 参与各种呼吸道疾病的气道免疫反应和发病机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta medica Okayama
Acta medica Okayama 医学-医学:研究与实验
CiteScore
1.00
自引率
0.00%
发文量
110
审稿时长
6-12 weeks
期刊介绍: Acta Medica Okayama (AMO) publishes papers relating to all areas of basic and clinical medical science. Papers may be submitted by those not affiliated with Okayama University. Only original papers which have not been published or submitted elsewhere and timely review articles should be submitted. Original papers may be Full-length Articles or Short Communications. Case Reports are considered if they describe significant and substantial new findings. Preliminary observations are not accepted.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信